We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of STAB yet.

STAB Hedge Fund Activity: Q3 2024 in Review

1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q3 2024, worth a combined $0 — down 100% from $1 a quarter earlier.

Fund positioning in STAB was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Statera Biopharma, Inc. Common Stock (STAB) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $0 of Statera Biopharma, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Statera Biopharma, Inc. Common Stock positions in Q3 2024 and 0 closed out.

Based on aggregated 13F filings for Q3 2024.